Thanks groberts. Been away awhile, but good to see you're on top of it!
dak, I agree mla could do more, however looking over the medivet media releases through online websites, social media and in person vet conferences they seem to be doing a pretty good job getting the brand and offering out there. If this starts translating through to significant sales, I don't have an issue with the single quarterly update from mla.
I've found a number of companies will continually release news and yet the companies end up raising capital, or downgrading prospects. I'm confident with the targets and bonus structure in place Ellis and co have reasonable motivation to get MLA humming, and if that means relative silence with a fairly informative quarterly I'm all for it.
Also, with no debt, cash in the bank, oem business profitable and potential in the medivet business (research and new pipeline of products progressing), I think things look pretty good for the future. Ultimately though it's up to each shareholder and if you're uncomfortable or unhappy you have to make that call.
Liquidity is always going to be tight with the top 20 holding how it is, scares some people off, but The likes of pie's recent holding and billionaire Lang walker, some heavy hitters acknowledge MLAs potential and the long term story.
Dyor GLTA etc...
MLA Price at posting:
8.9¢ Sentiment: Buy Disclosure: Held
